Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Living Modified Organism
(LMO)
The image below identifies the LMO through its unique identifier, trade name and a link to this page of the BCH. Click on it to download a larger image on your computer. For help on how to use it go to the LMO quick-links page.
Swine influenza virus vaccine
EN
H1N1 NS1
No
-
Person:Dra Patrícia Schwarztechnician in charge representing,Avenida das Nações Unidas, 14171, 18º andar - Torre B - Vila Gertrudes. 04794-000.São Paulo, São Paulo
04794-000, BrazilPhone: 55 11 4949-4700,Fax: 55 11 4949-4700,Website: http://www.boehringer-ingelheim.com.br/,Related OrganizationBoheringer Ingelheim Química e Farmacêutica Ltda. ()Private sector (business and industry)Avenida das Nações Unidas, 14171, 18º andar - Torre B - Vila Gertrudes. 04794-000.São Paulo, São Paulo
04794-000, BrazilPhone: 55 11 4949-4700,Fax: 55 11 4949-4700,Website: http://www.boehringer-ingelheim.com.br/,
The swine influenza vaccine is a bivalent vaccine containing two modified virions, H1N1 and H3N2, for developing immunity to both viruses. The modified H1N1 expresses H1N1 hemagglutinin (HA) and neuraminidase (NA), while the modified H3N2 expresses H3N2 HA and NA proteins. The other eight influenza proteins are from H3N2 for both modified virions. Attenuation was achieved by a truncation in the carboxy end of nonstructural protein 1. The vaccine was created through the transfection of eight plasmids corresponding to each viral genomic segment for each virus (separately). The fractions (H1N1 and H3N2) were later combined to create the vaccine.
EN
The term “Recipient organism” refers to an organism (either already modified or non-modified) that was subjected to genetic modification, whereas “Parental organisms” refers to those that were involved in cross breeding or cell fusion.
-
BCH-ORGA-SCBD-45782-7 Organism Influenza A virus (Influenza, Flu, Avian flu, Human flu, Swine influenza, Equine influenza, Bird flu)Viruses
EN
plasmid pHW2000
EN
- Direct DNA transfer (plasmid-based transfection)
|
0.350 kb
|
|
0.033 kb
|
|
2.333 kb
|
|
0.225 kb
|
|
0.227 kb
|
|
0.350 kb
|
|
0.033 kb
|
|
2.326 kb
|
|
0.225 kb
|
|
0.227 kb
|
|
0.350 kb
|
|
0.033 kb
|
|
2.194 kb
|
|
0.230 kb
|
|
0.230 kb
|
|
0.350 kb
|
|
0.033 kb
|
|
1.701 kb
|
|
0.230 kb
|
|
0.230 kb
|
|
0.350 kb
|
|
0.033 kb
|
|
1.564 kb
|
|
0.230 kb
|
|
0.230 kb
|
|
0.350 kb
|
|
0.033 kb
|
|
1.410 kb
|
|
0.225 kb
|
|
0.227 kb
|
|
0.350 kb
|
|
0.033 kb
|
|
0.025 kb
|
|
0.758 kb
|
|
0.267 kb
|
|
0.225 kb
|
|
0.227 kb
|
|
0.350 kb
|
|
0.033 kb
|
|
0.029 kb
|
|
0.378 kb
|
|
0.335 kb
|
|
0.225 kb
|
|
0.227 kb
|
|
0.350 kb
|
|
0.033 kb
|
|
2.333 kb
|
|
0.225 kb
|
|
0.227 kb
|
|
0.350 kb
|
|
0.033 kb
|
|
2.326 kb
|
|
0.225 kb
|
|
0.227 kb
|
|
0.350 kb
|
|
0.033 kb
|
|
2.194 kb
|
|
0.225 kb
|
|
0.227 kb
|
|
0.350 kb
|
|
0.033 kb
|
|
1.762 kb
|
|
0.225 kb
|
|
0.227 kb
|
|
0.350 kb
|
|
0.033 kb
|
|
1.564 kb
|
|
0.225 kb
|
|
0.227 kb
|
|
0.350 kb
|
|
0.033 kb
|
|
1.464 kb
|
|
0.225 kb
|
|
0.227 kb
|
|
0.350 kb
|
|
0.033 kb
|
|
0.025 kb
|
|
0.758 kb
|
|
0.267 kb
|
|
0.225 kb
|
|
0.227 kb
|
|
0.350 kb
|
|
0.033 kb
|
|
0.029 kb
|
|
0.378 kb
|
|
0.335 kb
|
|
0.225 kb
|
|
0.227 kb
|
Some of these genetic elements may be present as fragments or truncated forms. Please see notes below, where applicable.
-
BCH-GENE-SCBD-45883-4 Hemagglutinin gene | Influenza A virus (Influenza, Flu, Avian flu, Human flu, Swine influenza, Equine influenza, Bird flu)Protein coding sequence | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
-
BCH-GENE-SCBD-115567-3 Nonstructural protein 1 | Influenza A virus (Influenza, Flu, Avian flu, Human flu, Swine influenza, Equine influenza, Bird flu)Protein coding sequence
-
BCH-GENE-SCBD-115568-1 Polymerase acidic protein | Influenza A virus (Influenza, Flu, Avian flu, Human flu, Swine influenza, Equine influenza, Bird flu)Protein coding sequence
-
BCH-GENE-SCBD-115569-1 Polymerase basic protein 1 | Influenza A virus (Influenza, Flu, Avian flu, Human flu, Swine influenza, Equine influenza, Bird flu)Protein coding sequence
-
BCH-GENE-SCBD-115570-1 Polymerase basic protein 2 | Influenza A virus (Influenza, Flu, Avian flu, Human flu, Swine influenza, Equine influenza, Bird flu)Protein coding sequence
-
BCH-GENE-SCBD-115571-1 Nucleoprotein | Influenza A virus (Influenza, Flu, Avian flu, Human flu, Swine influenza, Equine influenza, Bird flu)Protein coding sequence
-
BCH-GENE-SCBD-115573-1 Neuraminidase | Influenza A virus (Influenza, Flu, Avian flu, Human flu, Swine influenza, Equine influenza, Bird flu)Protein coding sequence
-
BCH-GENE-SCBD-115574-1 Matrix protein 1 | Influenza A virus (Influenza, Flu, Avian flu, Human flu, Swine influenza, Equine influenza, Bird flu)Protein coding sequence
-
BCH-GENE-SCBD-115572-1 Matrix protein 2 | Influenza A virus (Influenza, Flu, Avian flu, Human flu, Swine influenza, Equine influenza, Bird flu)Protein coding sequence
-
BCH-GENE-SCBD-115575-2 Nuclear export protein | Influenza A virus (Influenza, Flu, Avian flu, Human flu, Swine influenza, Equine influenza, Bird flu)Protein coding sequence
-
BCH-GENE-SCBD-115580-1 Bovine growth hormone terminator | Bos taurus - Cow, Cattle, Bull, Auroch, Oxen, BullocksTerminator
-
BCH-GENE-SCBD-103749-1 Human Cytomegalovirus promoter | Human betaherpesvirus 5 (Human cytomegalovirus, HCMV, HHV-5)Promoter
-
BCH-GENE-SCBD-115581-2 Human polymerase 1 promoter | Homo sapiens (HUMAN)Promoter
-
BCH-GENE-SCBD-115582-2 Polymerase I terminator | Mus musculus (Mouse, House mouse, MOUSE)Terminator
Transcription
Eight expression plasmids (pHW2000) corresponding to the viral genomic segments were transfected to express all influenza genes. The first eight genetic constructs above are for the H1N1 fraction and the later 8 are for the H3N2 fractions of the vaccine. The plasmid contains bidirectional sets of expression cassettes: Cytomegalovirus promoter - Bovine growth hormone terminator (sense) and Human polymerase I promoter - Mus musculus polymerase I terminator (antisense). The combination of transcription in both directions and interaction with host cellular machinery results in the production of infectious virions.
For protein expression of the influenza genes, transcription by RNA polymerase II is directed from the Cytomegalovirus promoter and terminates at the bovine hormone terminator. For segments VII and VII (matrix protein 2 and nuclear export protein, respectively), the transcripts will be spliced to join the initial coding sequences to the later sequences and form a mature mRNA. The transcripts receive 5' caps and 3' poly-adenylated tails. Thus, the transcripts are translated into proteins. To produce viral RNA to function as genomic material, transcription must produce negative sense (antisense) cRNA. Thus, transcription is directed from the human polymerase I promoter and terminates at the Mus musculus polymerase I terminator. These transcripts have a 5' triphosphate group and no polyadenylated tail. Thus, they are not translated into proteins.
Sequence source
H1N1 modified virion (Lot no. 241-192) - first eight genetic constructs above
Influenza strain A/swine/Minnesota/37866/1999 (H1N1): HA and NA proteins
Influenza strain A/Swine/Texas/4199-2/98 (H3N2): PB1, PB2, PA, NP, M1, M2, NS1 and NEP
H3N2 modified virion (Lot no. 241-196) - later eight genetic constructs above
Influenza strain A/Swine/Texas/4199-2/98 (H3N2): PB1, PB2, PA, HA, NP, NA, M1, M2, NS1 and NEP
Note:
For both modified virions, the nonstructural protein 1 (NS1) has been carboxyl-truncated and codes for amino acids 1 to 126 of the native protein. The truncation is related to the attenuation (reduction in virulence) of the seed virus.
EN
Eight expression plasmids (pHW2000) corresponding to the viral genomic segments were transfected to express all influenza genes. The first eight genetic constructs above are for the H1N1 fraction and the later 8 are for the H3N2 fractions of the vaccine. The plasmid contains bidirectional sets of expression cassettes: Cytomegalovirus promoter - Bovine growth hormone terminator (sense) and Human polymerase I promoter - Mus musculus polymerase I terminator (antisense). The combination of transcription in both directions and interaction with host cellular machinery results in the production of infectious virions.
For protein expression of the influenza genes, transcription by RNA polymerase II is directed from the Cytomegalovirus promoter and terminates at the bovine hormone terminator. For segments VII and VII (matrix protein 2 and nuclear export protein, respectively), the transcripts will be spliced to join the initial coding sequences to the later sequences and form a mature mRNA. The transcripts receive 5' caps and 3' poly-adenylated tails. Thus, the transcripts are translated into proteins. To produce viral RNA to function as genomic material, transcription must produce negative sense (antisense) cRNA. Thus, transcription is directed from the human polymerase I promoter and terminates at the Mus musculus polymerase I terminator. These transcripts have a 5' triphosphate group and no polyadenylated tail. Thus, they are not translated into proteins.
Sequence source
H1N1 modified virion (Lot no. 241-192) - first eight genetic constructs above
Influenza strain A/swine/Minnesota/37866/1999 (H1N1): HA and NA proteins
Influenza strain A/Swine/Texas/4199-2/98 (H3N2): PB1, PB2, PA, NP, M1, M2, NS1 and NEP
H3N2 modified virion (Lot no. 241-196) - later eight genetic constructs above
Influenza strain A/Swine/Texas/4199-2/98 (H3N2): PB1, PB2, PA, HA, NP, NA, M1, M2, NS1 and NEP
Note:
For both modified virions, the nonstructural protein 1 (NS1) has been carboxyl-truncated and codes for amino acids 1 to 126 of the native protein. The truncation is related to the attenuation (reduction in virulence) of the seed virus.
EN
- Vaccine
EN
EN
- A DNA transfection system for generation of influenza A virus from eight plasmids.pdf [ English ]
- Influenza Research Database: Influenza strain A/swine/Minnesota/37866/1999 [ English ]
- Influenza Research Database: Influenza strain A/Swine/Texas/4199-2 /98 (H3N2) [ English ]
- Functional Replacement of the Carboxy-Terminal Two-Thirds of the Influenza A Virus NS1 Protein with Short Heterologous Dimerization Domains.pdf [ English ]
- Unidirectional RNA polymerase I–polymerase II transcription system for the generation of influenza A virus from eight plasmids.pdf [ English ]
| Record type | Field | Record(s) | |
|---|---|---|---|
| Country's Decision or any other Communication | LMO identification | 1 | |
| Risk Assessment generated by a regulatory process | Living modified organism(s) | 1 | |